Nidufexor, a non-bile acid FXR agonist, decreases ALT and hepatic fat fraction in patients with NASH after 12 weeks dosing Richard Aspinall, Mustafa Shennak,George Stocia, Dean Quinn,Lali Javashvili,Valentina Molteni,Chinweike Ukomadu, Bindi Sohal,Yiming Zhang,Miljen Martic, Alexandre Avrameas,Sheena Kao, Jacques Herve,Rachel Soon,Michael BadmanJournal of Hepatology（2020）引用 7|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
